N

Nexstim Oyj
OMXH:NXTMH

Watchlist Manager
Nexstim Oyj
OMXH:NXTMH
Watchlist
Price: 8.36 EUR 1.95%
Market Cap: 59.9m EUR
Have any thoughts about
Nexstim Oyj?
Write Note

Gross Margin
Nexstim Oyj

97.2%
Current
97%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
97.2%
=
Gross Profit
7.7m
/
Revenue
7.9m

Gross Margin Across Competitors

Country FI
Market Cap 56.6m EUR
Gross Margin
97%
Country US
Market Cap 199.9B USD
Gross Margin
56%
Country US
Market Cap 191.9B USD
Gross Margin
67%
Country US
Market Cap 140.8B USD
Gross Margin
64%
Country US
Market Cap 134.7B USD
Gross Margin
69%
Country IE
Market Cap 104.7B USD
Gross Margin
65%
Country US
Market Cap 65.9B USD
Gross Margin
45%
Country DE
Market Cap 58.1B EUR
Gross Margin
38%
Country US
Market Cap 44.8B USD
Gross Margin
79%
Country CN
Market Cap 314.4B CNY
Gross Margin
64%
Country US
Market Cap 36.4B USD
Gross Margin
41%
No Stocks Found

Nexstim Oyj
Glance View

Market Cap
56.6m EUR
Industry
Health Care

Nexstim Oyj engages in the provision of medical technology products. The company is headquartered in Helsinki, Etela-Suomen and currently employs 37 full-time employees. The company went IPO on 2014-11-14. The company is focused on improving rehabilitation for stroke patients through the use of noninvasive brain stimulation. Its offering comprises: a diagnostic tool for brain surgery planning, Navigated Brain Stimulation (NBS) System, which comprises navigated transcranial magnetic stimulation (nTMS) device for presurgical mapping (PSM) of the motor and speech cortices; and a device for stroke therapy called Navigated Brain Therapy (NBT) System, which focuses stimulation on targeted locations in the brain in order to enhance rehabilitation process. The NBT System targets upper limb motor disability and is under Phase III pivotal clinical trial study at rehabilitation sites in the United States. The Company’s systems are used in over 100 facilities in research, therapy and neurosurgical planning purposes. Nexstim Oyj has two subsidiaries: Nexstim Inc and Nexstim Germany GmbH.

NXTMH Intrinsic Value
6.19 EUR
Overvaluation 26%
Intrinsic Value
Price
N

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
97.2%
=
Gross Profit
7.7m
/
Revenue
7.9m
What is the Gross Margin of Nexstim Oyj?

Based on Nexstim Oyj's most recent financial statements, the company has Gross Margin of 97.2%.